GlassScriptPhysician profile
Praba Jeyalingam
NPI 1811217706
$5,263.75
in general payments reported to CMS, 2019-2025
36 companies · $549 in 2025
The $549 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $130 · 2021: $241 · 2022: $2,090 · 2023: $483 · 2024: $1,317 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,588 · Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,587.83 |
| Food and Beverage | $759.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,711.61 | 2024-2025 | Gelpoint V-Path |
| Intuitive Surgical, INC. | $1,429.92 | 2022 | |
| Pfizer INC. | $346.90 | 2019-2024 | |
| Abbvie INC. | $275.90 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $160.97 | 2019-2024 | Gardasil 9, Gardasil, Keytruda |
| Daiichi Sankyo INC. | $139.42 | 2019-2023 | Injectafer |
| Astellas Pharma US INC | $94.78 | 2021-2024 | Veozah |
| Eisai INC. | $82.06 | 2021-2023 | |
| Myovant Sciences INC. | $80.59 | 2022 | |
| Caldera Medical, INC | $68.85 | 2022 | |
| Hologic Sales and Service, LLC | $63.77 | 2019-2024 | Thinprep 2000 Processor |
| Exeltis, USA INC. | $62.37 | 2019-2023 | Slynd |
| Gynesonics, INC. | $62.26 | 2022 | |
| Amag Pharmaceuticals, INC. | $55.67 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $55.50 | 2023 | Myfembree |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $51.02 | 2021-2022 | |
| Medtronic, INC. | $47.23 | 2023 | Truclear |
| Genmab U.S., INC. | $46.99 | 2023 | Tivdak |
| Duchesnay USA Incorporated | $45.30 | 2019 | |
| Coopersurgical, INC. | $41.73 | 2021-2025 | Ally II Ups |
| Amgen INC. | $41.53 | 2019-2020 | |
| Meditrina | $35.34 | 2021 | |
| Boston Scientific Corporation | $31.62 | 2023 | |
| Vertical Pharmaceuticals, LLC | $26.99 | 2019 | |
| Millicent US INC | $24.08 | 2019 | |
| Therapeuticsmd, INC. | $23.63 | 2020 | |
| Glaxosmithkline, LLC. | $21.35 | 2023 | Jemperli |
| Gilead Sciences, INC. | $20.27 | 2022 | |
| Organogenesis INC. | $17.17 | 2021 | |
| Avion Pharmaceuticals | $17.11 | 2020 | |
| Mission Pharmacal Company | $15.88 | 2019 | |
| Novo Nordisk INC | $15.20 | 2023 | Wegovy |
| Axonics, INC. | $14.45 | 2021 | |
| Urovant Sciences INC | $13.09 | 2022 | |
| Baudax Bio INC. | $12.03 | 2022 | |
| Allergan, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praba Jeyalingam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.